Thomas Whelan
Family Medicine · Brookfield, CTNPI 1972543692
Payments from drug & device makers
Across 233 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$744
- AbbVie$715
- Pfizer$683
- GSK$333
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$275
- Takeda Pharmaceuticals U.S.A., Inc.$189
- plus $1K from 27 others
What the payments were for
- Food & beverage$4,282100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $744 |
| AbbVie | 41 | $715 |
| Pfizer | 40 | $683 |
| GSK | 15 | $333 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $275 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $189 |
| Johnson & Johnson(2 entities) | 9 | $152 |
| Eisai Inc. | 5 | $133 |
| Boston Scientific | 8 | $128 |
| Merck | 7 | $118 |
| Exact Sciences | 6 | $116 |
| Abbott | 4 | $77 |
| Amneal Pharmaceuticals LLC | 3 | $55 |
| Bayer | 2 | $51 |
| Novo Nordisk | 2 | $48 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Medtronic | 2 | $41 |
| Ironwood Pharmaceuticals, Inc | 2 | $38 |
| Lilly USA, LLC | 1 | $31 |
| Upsher-smith Laboratories LLC | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Krystal Biotech Inc | 1 | $25 |
| Shield Therapeutics Inc | 1 | $25 |
| Seqirus USA Inc | 1 | $24 |
| Organon | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Linus Health, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Philips North America LLC | 1 | $17 |
| Intra-sana Laboratories | 1 | $16 |
| Vistapharm, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$4,284 in reported general payments places this provider in the 85th percentile of 588 family medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $28,479 |
| JanuviaSitagliptin Phosphate | 15 | $21,002 |
| MounjaroTirzepatide | 19 | $20,476 |
| JardianceEmpagliflozin | 14 | $11,830 |
| Celecoxib | 116 | $5,363 |
| Atorvastatin Calcium | 147 | $1,801 |
| Levothyroxine Sodium | 116 | $1,771 |
| Rosuvastatin Calcium | 115 | $1,658 |
| PaxlovidNirmatrelvir/Ritonavir | 12 | $1,429 |
| Ibandronate Sodium | 36 | $1,168 |
| Escitalopram Oxalate | 60 | $1,015 |
| Irbesartan | 18 | $965 |
| Losartan Potassium | 105 | $929 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $807 |
| Trazodone Hcl | 63 | $695 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $683 | $29,90847 claims |
| MerckJanuvia | $118 | $21,00215 claims |
| Lilly USA, LLCMounjaro | $31 | $20,47619 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $55 | $1,771116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 588 family medicine providers in Connecticut.
Other family medicine in Brookfield
- Jeannie KenkareBrookfield$24K
- Debra GramlichStamford$292K
- Hadrian HolderNew Haven$213K
- Theodore BrunoDurham$201K
- Kenneth DardickStorrs$146K
- Raymond KurkerSouth Windsor$107K
- Thao DoranMarlborough$102K
- Raja FattalehPutnam$53K
- Nicholas TzikasNew Haven$46K
- Andrew SelingerBristol$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.